Within the realm of the AKT/mTOR pathway, we specifically determined that proteins involved in mRNA translational regulation were being upregulated in CLL patient samples, revealing a potential characteristic of CLL oncogenesis. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.